Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Epistatic interactions can moderate the antigenic effect of substitutions in haemagglutinin of influenza H3N2 virus.

Koel BF, Burke DF, van der Vliet S, Bestebroer TM, Rimmelzwaan GF, Osterhaus ADME, Smith DJ, Fouchier RAM.

J Gen Virol. 2019 May;100(5):773-777. doi: 10.1099/jgv.0.001263. Epub 2019 Apr 24.

PMID:
31017567
2.

The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses.

Linster M, Schrauwen EJA, van der Vliet S, Burke DF, Lexmond P, Bestebroer TM, Smith DJ, Herfst S, Koel BF, Fouchier RAM.

J Virol. 2019 Apr 3;93(8). pii: e01907-18. doi: 10.1128/JVI.01907-18. Print 2019 Apr 15.

PMID:
30700609
3.

The global antigenic diversity of swine influenza A viruses.

Lewis NS, Russell CA, Langat P, Anderson TK, Berger K, Bielejec F, Burke DF, Dudas G, Fonville JM, Fouchier RA, Kellam P, Koel BF, Lemey P, Nguyen T, Nuansrichy B, Peiris JM, Saito T, Simon G, Skepner E, Takemae N; ESNIP3 consortium, Webby RJ, Van Reeth K, Brookes SM, Larsen L, Watson SJ, Brown IH, Vincent AL.

Elife. 2016 Apr 15;5:e12217. doi: 10.7554/eLife.12217.

4.

Identification of amino acid substitutions supporting antigenic change of influenza A(H1N1)pdm09 viruses.

Koel BF, Mögling R, Chutinimitkul S, Fraaij PL, Burke DF, van der Vliet S, de Wit E, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Smith DJ, Fouchier RA, de Graaf M.

J Virol. 2015 Apr;89(7):3763-75. doi: 10.1128/JVI.02962-14. Epub 2015 Jan 21.

5.

Serological evidence for non-lethal exposures of Mongolian wild birds to highly pathogenic avian influenza H5N1 virus.

Gilbert M, Koel BF, Bestebroer TM, Lewis NS, Smith DJ, Fouchier RA.

PLoS One. 2014 Dec 15;9(12):e113569. doi: 10.1371/journal.pone.0113569. eCollection 2014.

6.

Antigenic variation of clade 2.1 H5N1 virus is determined by a few amino acid substitutions immediately adjacent to the receptor binding site.

Koel BF, van der Vliet S, Burke DF, Bestebroer TM, Bharoto EE, Yasa IW, Herliana I, Laksono BM, Xu K, Skepner E, Russell CA, Rimmelzwaan GF, Perez DR, Osterhaus AD, Smith DJ, Prajitno TY, Fouchier RA.

MBio. 2014 Jun 10;5(3):e01070-14. doi: 10.1128/mBio.01070-14. Erratum in: MBio. 2014;5(4):doi:10.1128/mBio.01645-14.

7.

Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.

Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G, Skepner E, Lewis NS, Spronken MI, Russell CA, Eropkin MY, Hurt AC, Barr IG, de Jong JC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA, Smith DJ.

Science. 2013 Nov 22;342(6161):976-9. doi: 10.1126/science.1244730.

8.

Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors.

Sprangers MC, Lakhai W, Koudstaal W, Verhoeven M, Koel BF, Vogels R, Goudsmit J, Havenga MJ, Kostense S.

J Clin Microbiol. 2003 Nov;41(11):5046-52.

Supplemental Content

Support Center